Bharat Biotech, Biovet and Sapigen Biologix collaborate with CSIR-IICT on healthcare for humans, animals

Vaccine maker Bharat Biotech, Biovet and Sapigen Biologix on Monday signed a collaborative research agreement with CSIR-Indian Institute of Chemical Technology (IICT) here to collaborate on the development of novel platform technologies for biotherapeutics and vaccines to support affordable healthcare solutions for humans and animals. The Master Collaborative Agreement (MCA) was signed here by Bharat Biotech International, Biovet, Sapigen Biologix with the IICT in the presence of Bharat Biotech CMD Krishna Ella, CSIR DG Shekhar C Mande, IICT Director S Chandrasekhar and others. The collaborators would identify mutually interesting projects to pursue under the agreement, a CSIR-IICT release said.

Bharat Biotech, Biovet and Sapigen Biologix intend to strengthen the "excellent working relationship" between the organisations, by conducting studies on futuristic vaccines, bio-therapeutic formulations, delivery strategies and also explore innovative solutions to the vaccination administration process. Image credit: AP Illustration/Peter Hamlin

As a part of the MCA, the Industry collaborators shall provide necessary financial support to CSIR-IICT for developing key raw materials required by the collaborators, and also perform "in-vitro and in vivo studies" for further development of potential vaccine candidates and bio-therapeutics formulations to be designed by the collaborators.

The broad-based MCA enables the partners to take up futuristic development activities in other related areas as well, it said.

The MCA follows the contribution by CSIR-IICT during February 2021, in developing a synthetic process route for adjuvant molecule TLR 7/8 to BBIL for Covaxin, the indigenous vaccine rolled out by BBIL.

The partners intend to strengthen the "excellent working relationship" between the organisations, by conducting studies on futuristic vaccines, bio-therapeutic formulations, delivery strategies and also explore innovative solutions to the vaccination administration process.

Biovet is a leader in animal vaccines, while Sapigen Biologix is engaged in research, design, development of technical know-how in all kinds of work in the fields of Biology, Bio-technology and others, according to the release. Addressing the gathering, Krishna Ella talked about the dependence on imports for some of the raw materials and the need to address the issue.

"When you want to leapfrog the vaccine field, we need other ancillary industries to come up, other technologies to come up along with it. Otherwise, I don't think, biotechnology field, we will go (far ahead). We will be importing a lot of stuff from other places..," he said.

Noting that some raw materials could not be obtained from the US due to certain restrictions imposed by that country, he said such problems needed to be anticipated in the future.

"That is one of the reasons why we said, let's partner (with CSIR)...," he said.

Asked about how the issue of shortage of raw materials would be addressed, Mande referred to the goal of ''Atma Nirbhar Bharat''and that the government is very keen on generating as many resources as possible within the country.

"Shortage of chemicals that probably is being asked is only one aspect of that. What we would like to take is a much larger view and try to see that as much as possible, we would like to be self-dependent," he said.

However, the statement of self-dependent on raw materials does not mean remaining inward-looking (that nothing will be imported) and the government is keen on having the capability, capacity and confidence that everything can be done in the country, Mande said.

About how the agreement would work, he said true collaborations involve exchange of ideas between different parties and working together and not working in isolation.

He said CSIR and Bharat Biotech are looking at bringing mRNA based vaccine platform in the country.

"For example, today there is a need felt that India must have a vaccine platform which is let us say mRNA based. Today, we don''t have an mRNA based vaccine platform in the country." "Dr Ella and us are already talking about it that how do we actually bring it and Dr Ella is very confident that in the coming few months we will be able to actually bring it, this particular platform," Mande said.

He said mRNA has emerged as one of the most powerful technologies in the COVID pandemic.

Asked if the mRNA effort would be COVID specific, he said the CSIR, in its collaborations with companies, would like to cover different areas and many diseases together.

"When we do collaborations with companies, we always do long term, many different areas, many different diseases together. COVID also is a part of that. But, what we want to do is generate a platform here so that any other diseases or future pandemics can also be dealt with this kind of a platform," Mande added.



from Firstpost Tech Latest News https://ift.tt/31ynsur

Comments

Post a Comment

Popular posts from this blog

COVID-19 origins: Should we pay more attention to the lab leak theory and formally investigate it?

Image
A year and a half into the pandemic, we still do not know exactly where the SARS-CoV-2 virus, which causes Covid-19, came from. The prevailing view so far has been that the virus “spilled over” from bats into humans. But there are increasing calls to investigate the possibility that it emerged from a lab in Wuhan, China, where Covid first appeared at the end of 2019. So what do we know for sure, and what do we need still to find out? We know the sequence of the SARS-CoV-2 virus is close to that of bat coronaviruses . Several decades ago its “ancestor” was circulating in bat populations in southern Asia. But there are still many unanswered questions: we don’t know how the virus arrived in Wuhan, how its sequence evolved to allow human infection, and under what conditions it infected the first people who crossed its path. And for each of these stages, we don’t know whether there was a human contribution (direct or indirect). Zoonotic transmission pathways, in other words the pas
Read more

Menstrual cups are cheaper, more sustainable than pads and tampons for women

Image
Every year in America, women spend at least US$2.8 billion on sanitary pads and tampons that can take hundreds of years to decompose . Is there a more economical and environmentally friendly way? To find out, we asked Susan Powers , a professor of sustainable environmental systems at Clarkson University about her work comparing the environmental impact of tampons, sanitary pads and menstrual cups. What is a menstrual cup? A menstrual cup is a type of reusable feminine hygiene product. It’s a small, flexible bell-shaped cup made of rubber or silicone that a woman inserts into her vagina to catch and collect menstrual fluid. It can be used for up to 12 hours, after which it is removed to dispose of the fluid and cleaned. The cup is rinsed with hot water and soap between each insertion and sterilized in boiling water at least once per period. A cup can last up to 10 years . Although menstrual cups have been around for decades, they historically have been less popular than pads or ta
Read more

Human bodies respond to infections differently depending on the time of day

Image
When microorganisms – such as bacteria or viruses – infect us, our immune system jumps into action. It’s highly trained to sense and eliminate infections and clear up any damage caused by them. It’s typically assumed our immune systems work the exact same way regardless of whether an infection occurs during the day or at night. But research spanning over half a century now shows our bodies actually respond differently at day and night. The reason for this is our body clock, and the fact that each cell in the body, including our immune cells, can tell what time of day it is. Our body clock has evolved over millions of years to help us survive. Every cell in the body has a collection of proteins that indicate the time depending on their levels. Knowing whether it’s day or night means our body can adjust its functions and behaviours (such as when we want to eat) to the correct time. Our body clock does this by generating 24 hour rhythms (also termed circadian rhythms ) in how cells f
Read more